infi Revenue and Competitors

Claim your profile

Tel Aviv, Israel

Location

$40M

Total Funding

Estimated Revenue & Valuation

  • infi's estimated annual revenue is currently $600.3k per year.(i)
  • infi received $16.0M in venture funding in October 2017.
  • infi's estimated revenue per employee is $33,350
  • infi's total funding is $40M.

Employee Data

  • infi has 18 Employees.(i)
  • 0
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.5M14N/A$2.2MN/A
#2
$0.6M18N/A$40MN/A
#3
$0.1M9N/A$13.3MN/A
#4
$7.7M59-2%N/AN/A
#5
$2.4M240%N/AN/A
#6
$5.1M44-6%N/AN/A
#7
$5.3M46-6%N/AN/A
#8
$9.4M65N/AN/AN/A
#9
$110.6M763N/AN/AN/A
#10
$1.6M11N/AN/AN/A

infi is changing how millions of people around the world think, feel, decide and behave with its EmpathAI (Empathetic AI) platform. Using Deep Psychology to drive Deep Machine Learning and apply it to powerful predictive algorithms, EmpathAI offers unprecedented insights into each individuals unique traits, feelings and internal motivators. By replicating the thought processes of the human brain in the digital world, Infi knows what really matters, and what every individual really needs, in real-time. Welcome to the infi era

keywords:N/A

$40M

Total Funding

18

Number of Employees

$600.3k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

infi News

2022-04-19 - Infinity Pharmaceuticals (INFI) Set to Announce Quarterly ...

Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) will post its quarterly earnings results after the market closes on Tuesday, May 3rd.

2022-04-19 - Infinity Pharmaceuticals (INFI) Set to Announce Quarterly ...

Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) will post its quarterly earnings results after the market closes on Tuesday, May 3rd.

2022-04-13 - Head to Head Review: AstraZeneca (NASDAQ:AZN) and ...

Head to Head Review: AstraZeneca (NASDAQ:AZN) and Infinity Pharmaceuticals (NASDAQ:INFI). Posted by admin on Apr 22nd, 2022.

2022-04-13 - Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Receives ...

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Receives Average Recommendation of “Buy” from Analysts. Posted by admin on Apr 19th, 2022.

2022-04-13 - Head to Head Review: AstraZeneca (NASDAQ:AZN) and ...

Head to Head Review: AstraZeneca (NASDAQ:AZN) and Infinity Pharmaceuticals (NASDAQ:INFI). Posted by admin on Apr 22nd, 2022.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M18N/AN/A
#2
$1.6M18N/AN/A
#3
$4.5M18N/AN/A
#4
$1.7M18N/AN/A
#5
$2.3M18N/AN/A

infi Funding

DateAmountRoundLead InvestorsReference
2017-10-31$16.0MFirstArticle